http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CZ-375098-A3
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2ca2e4410855da087e11bf3eea8933fa |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4025 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-445 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P39-00 |
filingDate | 1997-05-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9317527b9de8624fc6690c1485753947 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0ad8117add4921e643a39565d6bfca92 |
publicationDate | 2000-01-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CZ-375098-A3 |
titleOfInvention | A pharmaceutical composition for enhancing endothelial nitric oxide synthesis |
abstract | The use of a 2-allylbenzo [b] thiophene derivative of the general formula (I), whereinnis RH, OH, -O-C 1-4 alkyl, -OCO-C 1-4 alkyl or -OOOAr,nwherein Ar is optionally substituted phenyl, R 1 is Cl or F anR 21 -pyrrolidinyl, 1-piperidinyl or 1-hexamethylenimino, orna pharmaceutically acceptable salt or solvate thereofnpharmaceutical compositions for increasing oxide synthesisnnitric in vascular endothelial cells of humans and pronthe preparation of a pharmaceutical composition for inhibiting physiologicalnconditions associated with deficiency or need for nitric oxide. |
priorityDate | 1997-05-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 289.